Moderna (MRNA) Accumulated Expenses (2017 - 2026)
Moderna (MRNA) reported Accumulated Expenses of $1.91 billion for Q2 2026, up 93.4% from $987 million a year earlier but down 0.2% from the prior quarter.
Powered by 
Analysis
Moderna (MRNA) Accumulated Expenses (2017 - 2026) Analysis & Trends
At the end of FY2025, Moderna posted Accumulated Expenses of $1.39 billion, down 2.9% from FY2024.
- Accumulated Expenses has declined for three consecutive years, though with a five-year compound annual growth rate of 24.1% (FY2020 to FY2025).
- By year, Accumulated Expenses came in at $1.43 billion in FY2024 (-20.6%), $1.8 billion in FY2023 (-14.4%), $2.1 billion in FY2022 (+42.7%) and $1.47 billion in FY2021 (+213.2%).
- Five-year quarterly Accumulated Expenses spans a low of $987 million in Q2 2025 and a high of $2.22 billion in Q3 2023.
- Year over year, Accumulated Expenses gained in two of the last eight quarters, with growth averaging 6.8%.
- The high point for year-over-year Accumulated Expenses in five years was Q3 2021 (growth of 415.2%); the low point was Q3 2024 (a decline of 38.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.91 billion (Q1 2026), $1.39 billion (Q4 2025) and $1.18 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 Bn |
| Mar 31, 2026 | 1.91 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Sep 30, 2025 | 1.18 Bn |
| Jun 30, 2025 | 987.00 Mn |
| Mar 31, 2025 | 1.00 Bn |
| Dec 31, 2024 | 1.43 Bn |
| Sep 30, 2024 | 1.38 Bn |
| Jun 30, 2024 | 1.33 Bn |
| Mar 31, 2024 | 1.40 Bn |
| Dec 31, 2023 | 1.80 Bn |
| Sep 30, 2023 | 2.22 Bn |
| Jun 30, 2023 | 1.49 Bn |
| Mar 31, 2023 | 1.61 Bn |
| Dec 31, 2022 | 2.10 Bn |
| Sep 30, 2022 | 1.86 Bn |
| Jun 30, 2022 | 1.78 Bn |
| Mar 31, 2022 | 1.61 Bn |
| Dec 31, 2021 | 1.47 Bn |
| Sep 30, 2021 | 1.08 Bn |
API Access
Moderna Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();